Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) statesTakeshi Yoshida, Junji Matsui|British Journal of Cancer|2014Cited by 355
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma modelsMasahiro Matsuki, Junji Matsui|Cancer Medicine|2018Cited by 258
Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial CellsJunji Matsui, Masayuki Okada|Journal of Biological Chemistry|2004Cited by 217
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Matt Barnes, Stuart Stafford et al.|European Journal of Pharmacology|2014Cited by 54
Tubulin is a molecular target of the Wnt-activating chemical probeYasunori Fukuda, Junji Matsui|BMC Biochemistry|2016Cited by 13